Non Hodgkin Lymphoma News and Research

RSS
Research reveals new standard treatment options for various forms of lymphoma

Research reveals new standard treatment options for various forms of lymphoma

New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

Pfizer to present data on hematology portfolio at ASH Annual Meeting

Pfizer to present data on hematology portfolio at ASH Annual Meeting

Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

EC grants orphan medicinal product designation to Allos' pralatrexate for Hodgkin lymphoma

EC grants orphan medicinal product designation to Allos' pralatrexate for Hodgkin lymphoma

Seattle Genetics reports SGN-75 phase I clinical trial data

Seattle Genetics reports SGN-75 phase I clinical trial data

Seattle Genetics to present SGN-75 phase I data at ESMO Congress

Seattle Genetics to present SGN-75 phase I data at ESMO Congress

NIH to award $64M under Transformative Research Projects program

NIH to award $64M under Transformative Research Projects program

Avila commences AVL-292 Phase 1 clinical study for B cell cancers and autoimmune diseases

Avila commences AVL-292 Phase 1 clinical study for B cell cancers and autoimmune diseases

National survey highlights need for greater awareness on lymphoma

National survey highlights need for greater awareness on lymphoma

CSC launches new educational program to enhance lymphoma patient, physician communication

CSC launches new educational program to enhance lymphoma patient, physician communication

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Incidence of blood based deficiencies is strong predictor of poor outcome in pSS patients: Study

Incidence of blood based deficiencies is strong predictor of poor outcome in pSS patients: Study

Study confirms impact of febrile neutropenia on chemotherapy delivery in NHL

Study confirms impact of febrile neutropenia on chemotherapy delivery in NHL

Research findings open door to development of new therapies for lymphomas, leukemias

Research findings open door to development of new therapies for lymphomas, leukemias

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Researchers develop new type of drug to kill non-Hodgkin lymphoma tumor cells

Researchers develop new type of drug to kill non-Hodgkin lymphoma tumor cells

Research roundup: Managing nursing home patients, streamlining medical billing, financial disclosures

Research roundup: Managing nursing home patients, streamlining medical billing, financial disclosures